Is a complete ETR/BXT research report available?

Question

Accepted Answer

No complete published report is available for etr/BXT (ETR/BXT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	29.7M
Net income (ttm)	-5.6M
EPS (ttm)	-€0.05
Volume	108,404
Beta	1.47

Metric	Value
Country	Canada
Country code	DE
Employees Change	19%
Employees Change Percent	1,900
Enterprise value	EUR 33.1M
Exchange	Deutsche Börse Xetra
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	26.74
Industry PE Fwd	16.37
Last refreshed	2026-09-06
Market cap	EUR 29.7M
Price	EUR 0.21
Price currency	EUR
Sector	Healthcare
Sector PE	37.99
Sector PE Fwd	14.33
Sic	2834
Symbol	etr/BXT
Website	https://www.bionxt.com

Metric	Value
Earnings Yield	-18.96%
FCF yield	-9.53%
P/B ratio	-7.71x

Metric	Value
Net Income	EUR -5.6M
ROA	-387.5
Roa5y	-280.5
ROCE	130.6

Metric	Value
Cagr1y	-67.01%
Cagr3y	-4.75%
Cagr5y	-28.14%

ETR/BXT (ETR/BXT)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/BXT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/BXT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/BXT

Frequently asked questions

Metric	Value
Assets	EUR 953,248
Cash	EUR 741,087
Current Assets	EUR 801,399
Current Liabilities	EUR 4.2M
Debt	EUR 4.1M
Debt FCF	EUR -1.45
Equity	EUR -3.9M
Interest Coverage	-4.31
Liabilities	EUR 4.8M
Long Term Assets	EUR 151,849
Long Term Liabilities	EUR 656,254
Net Cash	EUR -3.4M
Net Cash By Market Cap	EUR -11.37
Tangible Book Value	EUR -3.9M
Tangible Book Value Per Share	EUR -0.03
WACC	13.05

Metric	Value
Current ratio	0.19
Net Working Capital	EUR -634,852
Quick ratio	0.19
Working Capital	EUR -3.3M

Metric	Value
1Y total return	-66.98%
200-day SMA	0.31
3Y total return	-13.58%
50-day SMA	0.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-80.84%
All Time High	2.2
All Time High Change	-90.45%
All Time High Date	2020-05-29
All Time Low	0.1
All Time Low Change	110%
All Time Low Date	2023-10-23
ATR	0.02
Beta	1.47
Ch YTD	-52.81
High	0.24
High52	0.66
High52 Date	2025-09-05
High52ch	-68.18%
Low	0.2
Low52	0.17
Low52 Date	2026-08-04
Low52ch	23.53%
Ma50ch	1.01%
Price vs 200-day SMA	-32.48%
RSI	49.17
RSI Monthly	40.36
RSI Weekly	40.75
Sharpe ratio	-0.69x
Sharpe Ratio3y	0.45x
Sharpe Ratio5y	0.05x
Sortino ratio	-1
Sortino Ratio3y	0.84
Sortino Ratio5y	0.14
Total Return	-8.39%
Tr YTD	-52.81
Tr1m	-4.11%
Tr1w	-10.64%
Tr3m	-16%

Metric	Value
Float	128,566,452%
Net Borrowing	777,874.5
Shares Insiders	5.53%
Shares Qo Q	3.76%
Shares Yo Y	8.39%

Metric	Value
Adjusted FCF	EUR -4.7M
Adjusted OCF	-4,653,110.2
Average Volume	27,300.55x
Bv Per Share	-0.03
Ch1m	-4.11
Ch1w	-10.64
Ch1y	-66.98
Ch3m	-16
Ch3y	-13.58
Ch5y	-80.84
Ch6m	-48.66
Change	2.44%
Change From Open	-10.64
Close	0.21
Days Gap	14.63
Depreciation Amortization	7,357.6
Dollar Volume	22,764.8
Earnings Date	2026-09-10
EBIT	EUR -4.1M
EBITDA	EUR -4.1M
EPS	EUR -0.05
F Score	3
FCF	EUR -2.8M
FCF EV Yield	-8.55x
Financing CF	3,487,651
Fiscal Year End	December
Founded	2,017
Income Tax	EUR -121,713
Investing CF	56,865
Is Primary Listing	0
Last Earnings Date	2025-11-28
Last Report Date	2026-06-30
Ma150	0.28
Ma150ch	-25.66%
Ma20	0.21
Ma20ch	0.82%
Net CF	738,476
Next Earnings Date	2026-09-10
Open	0.24
Position In Range	21.87
Ppne	129,613.4
Price Date	2026-09-04
Relative Volume	3.97x
Share Based Comp	1,803,418
Tr6m	-48.66%
Volume	108,404